ClinConnect ClinConnect Logo
Search / Trial NCT06883734

The Effect of Illness Management Skill Training Applied to Patients with Schizophrenia

Launched by NESLIHAN LOK · Mar 13, 2025

Trial Information

Current as of April 29, 2025

Completed

Keywords

Schizophrenia Engulfment Quality Of Life Illness Management Recovery Illness Management Skills Training Psychiatric Nursing

ClinConnect Summary

The study examined 110 individuals aged 18-65 who were diagnosed with schizophrenia and applied to the S.U. Faculty of Medicine Mental Health and Diseases Polyclinic in the last year, according to the inclusion-exclusion criteria. A total of 50 individuals diagnosed schizophrenia were included in the study. These individuals were randomly assigned to two groups: intervention and control. Pre-test data were collected using the "Personal Information Form", "Modified Engulfment Scale", "SF 36 Quality of Life Scale" and "Illness Management and Recovery Scale-Patient Form" from the intervention ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being between the ages of 18-65,
  • Having been diagnosed with Schizophrenia for at least 6 months according to ICD-10,
  • Being registered with the Selcuk University Faculty of Medical Hospital Mental Health and Diseases Polyclinic,
  • Coming to the polyclinic for regular check-ups,
  • Getting a mild/moderate score from the Positive and Negative Syndrome Scale (PANSS),
  • Taking medication regularly,
  • Being at least literate.
  • Exclusion Criteria:
  • Having an organic mental disorder or mental retardation,
  • Having a visual or hearing impairment,
  • Participating in a program similar to the intervention to be implemented.

About Neslihan Lok

Neslihan Lok is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on therapeutic areas that address unmet medical needs, Neslihan Lok collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the highest standards of safety and efficacy in clinical trials. The organization prioritizes ethical practices and patient-centered approaches, striving to contribute valuable insights to the medical community and facilitate the development of new treatments that enhance the quality of care.

Locations

Konya, , Turkey

Patients applied

0 patients applied

Trial Officials

Neslihan Lok, Prof. Dr

Study Director

Selcuk University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported